ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,22
-1,51%
Dow Jones
42 732,13
0,80%
DAX
19 906,08
-0,49%
Brent Oil
76,495
0,00%
Bitcoin
98 101,28
-0,11%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Aadi Bioscience Inc (AADI) Cours

Aadi Bioscience Inc

Aadi Bioscience Inc (AADI)

NASDAQ
3,26
0,12
(3,82%)
Fermé 05 Janvier 10:00PM
Retardé de 15 minutes
3,156
-0,104
(-3,19%)
Après les heures de négociation: 12:48AM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
3,156
Prix Achat
3,11
Prix Vente
3,27
Volume échangé
288 772
3,10 Fourchette du Jour 3,28
1,21 Plage de 52 semaines 3,60
Cap du marché
77,787M
Clôture Veille
3,14
Ouverture
3,17
Dernière Transaction
1
@
3.27
Dernière heure de transaction
Volume financier
US$ 928 588
VWAP
3,2156
Volume moyen (3 m)
305 381
Actions en circulation
24 647 392
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,23
Bénéfice par action (BPA)
-2,67
Chiffre d'affairess
24,35M
Bénéfice net
-65,77M

À propos de Aadi Bioscience Inc

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other ... Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.aadibio.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Aadi Bioscience Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker AADI. Le dernier cours de clôture d'Aadi Bioscience était de US$3,14. Au cours de la dernière année, les actions de Aadi Bioscience ont été négociées dans une fourchette de prix de US$ 1,21 à US$ 3,60.

Aadi Bioscience compte actuellement 24 647 392 actions en circulation. La capitalisation boursière d'Aadi Bioscience est de US$77,39 million. Aadi Bioscience a un ratio cours/bénéfice (ratio PE) de -1.23.

AADI Dernières nouvelles

Plus de nouvelles

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

30 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

23 Décembre 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

23 Décembre 2024
Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

23 Décembre 2024
Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

23 Décembre 2024
Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

20 Décembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

20 Décembre 2024
Edgar (US Regulatory)

Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing

Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing PR Newswire LOS ANGELES, Dec. 19, 2024 Aadi Enters into Exclusive...

20 Décembre 2024
PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

06 Novembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

06 Novembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.0963.137254901963.063.292.873232783.11796305CS
40.79633.72881355932.363.62.077301573.22195702CS
121.16658.59296482411.993.61.9053053812.95423537CS
261.806133.7777777781.353.61.212636332.32813882CS
521.12655.46798029562.033.61.212803372.12827497CS
156-21.304-87.097301717124.4625.3551.211944655.86677949CS
260-26.844-89.483032.991.211895357.41751098CS

AADI - Frequently Asked Questions (FAQ)

What is the current Aadi Bioscience share price?
The current share price of Aadi Bioscience is US$ 3,156
How many Aadi Bioscience shares are in issue?
Aadi Bioscience has 24 647 392 shares in issue
What is the market cap of Aadi Bioscience?
The market capitalisation of Aadi Bioscience is USD 77,39M
What is the 1 year trading range for Aadi Bioscience share price?
Aadi Bioscience has traded in the range of US$ 1,21 to US$ 3,60 during the past year
What is the PE ratio of Aadi Bioscience?
The price to earnings ratio of Aadi Bioscience is -1,23
What is the cash to sales ratio of Aadi Bioscience?
The cash to sales ratio of Aadi Bioscience is 3,32
What is the reporting currency for Aadi Bioscience?
Aadi Bioscience reports financial results in USD
What is the latest annual turnover for Aadi Bioscience?
The latest annual turnover of Aadi Bioscience is USD 24,35M
What is the latest annual profit for Aadi Bioscience?
The latest annual profit of Aadi Bioscience is USD -65,77M
What is the registered address of Aadi Bioscience?
The registered address for Aadi Bioscience is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Aadi Bioscience website address?
The website address for Aadi Bioscience is www.aadibio.com
Which industry sector does Aadi Bioscience operate in?
Aadi Bioscience operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
260,93M
NITON2OFF Inc
US$ 2,6306
(145,85%)
358,28M
CRNCCerence Inc
US$ 19,33
(143,76%)
161,8M
KITTNauticus Robotics Inc
US$ 3,8249
(140,56%)
104,8M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,64M
HWHHWH International Inc
US$ 0,4621
(-28,80%)
7,43M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5,69
(-26,30%)
24,77M
RAINRain Enhancement Technologies Holdco Inc
US$ 5,59
(-23,42%)
161,15k
PTLEPTL Ltd
US$ 9,35
(-23,30%)
1,04M
NXUNXU Inc
US$ 0,725868
(-22,78%)
7,59M
NITON2OFF Inc
US$ 2,6306
(145,85%)
358,28M
TGLTreasure Global Inc
US$ 0,382
(101,58%)
337,5M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,64M
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
260,93M
NVDANVIDIA Corporation
US$ 144,47
(4,45%)
230,01M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
AADI
Aadi Bioscience
ASX
TDYDA
thedocyard
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés